Vanguard Medical Devices Limited
12215708
Some Concerns
- Negative net worth (-10)
- Current liabilities exceed current assets (-10)
- Going concern doubt noted in accounts (-10)
Details
Compliance
Last accounts
31/12/2025
small
Next accounts due
30/09/2027
Confirmation statement
Last: 18/09/2025
Due 02/10/2026
Industry
Officers
Persons with Significant Control
Mr Thomas Peter Maier
German · Germany · Age 59
The Scalpel, 18th Floor, London, EC3M 7AF
Notified 16/10/2024
CompanyRankvs 1469+ SIC 32500 peers25
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
upon the support of its parent company to continue as a going concern. These conditions indicate that a material uncertainty exists that may cast doubt on the company's ability to continue as a going concern. PARENT COMPANY The immediate parent undertaking of Vanguard Medical Devices LTD is Vanguard AG, a Company incorporated in Germany with registered office at Landsberger Str. 222, 12623 Berlin,
Key FinancialsYear ending 31/12/2025
Net Worth
-£1.8M
Balance sheet strength
Cash
£69k
Cash in the bank
Net Current Assets
-£258k
Working capital
Current Assets
£258k
Current Liabilities
£516k
Fixed Assets
£2k
Debtors
£172k
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2025 | 0.50 |
| 2024 | 0.01 |
| 2023 | 0.20 |
Derived from filed accounts. Not audited figures.